George Canellos
George Canellos | |
|---|---|
| Nationality | American |
| Alma mater | Harvard University, Columbia University College of Physicians and Surgeons |
| Known for | Development of combination chemotherapy regimens |
| Scientific career | |
| Fields | Oncology |
| Institutions | Dana-Farber Cancer Institute, Harvard Medical School |
George Canellos is an American oncologist known for his contributions to the development of combination chemotherapy regimens for the treatment of various types of cancer. He has held prominent positions at the Dana-Farber Cancer Institute and Harvard Medical School.
Early Life and Education[edit | edit source]
George Canellos was born in Boston, Massachusetts. He completed his undergraduate studies at Harvard University and earned his medical degree from the Columbia University College of Physicians and Surgeons.
Career[edit | edit source]
After completing his medical training, Canellos joined the National Cancer Institute (NCI), where he worked on early chemotherapy trials. He later moved to the Dana-Farber Cancer Institute, where he became a leading figure in the field of oncology.
Contributions to Oncology[edit | edit source]
Canellos is best known for his work in developing combination chemotherapy regimens, which have significantly improved the treatment outcomes for patients with various types of cancer, including Hodgkin lymphoma and non-Hodgkin lymphoma. His research has focused on optimizing the use of multiple drugs to enhance their effectiveness while minimizing side effects.
Positions and Honors[edit | edit source]
Throughout his career, Canellos has held several prestigious positions, including Chief of the Division of Medical Oncology at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He has also served as the editor-in-chief of the Journal of Clinical Oncology.
Personal Life[edit | edit source]
George Canellos is married and has children. He continues to be active in the field of oncology, contributing to research and mentoring the next generation of oncologists.
See Also[edit | edit source]
- Oncology
- Chemotherapy
- Dana-Farber Cancer Institute
- Harvard Medical School
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
